Human immunodeficiency virus type I Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA

被引:111
作者
Khan, MA
Aberham, C
Kao, S
Akari, H
Gorelick, R
Bour, S
Strebel, K
机构
[1] NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, SAIC Frederick, AIDS Vaccine Program, Frederick, MD 21701 USA
关键词
D O I
10.1128/JVI.75.16.7252-7265.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) Vif protein plays a critical role in the production of infectious virions. Previous studies have demonstrated the presence of small amounts of Vif in virus particles. However, Vif packaging was assumed to be nonspecific, and its functional significance has been questioned. We now report that packaging of Vif is dependent on the packaging of viral genomic RNA in both permissive and restrictive HIV-1 target cells. Mutations in the nucleocapsid zinc finger domains that abrogate packaging of viral genomic RNA abolished packaging of Vif. Additionally, an RNA packaging-defective virus exhibited significantly reduced packaging of Vif. Finally, deletion of a putative RNA-interacting domain in Vif abolished packaging of Vif into virions. Virion-associated Vif was resistant to detergent extraction and copurified with components of the viral nucleoprotein complex and functional reverse transcription complexes. Thus, Vif is specifically packaged into virions as a component of the viral nucleoprotein complex. Our data suggest that the specific association of Vif with the viral nucleoprotein complex might be functionally significant and could be a critical requirement for infectivity of viruses produced from restrictive host cells.
引用
收藏
页码:7252 / 7265
页数:14
相关论文
共 72 条
  • [41] An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
    Madani, N
    Kabat, D
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (12) : 10251 - 10255
  • [42] High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells
    Mochizuki, H
    Schwartz, JP
    Tanaka, K
    Brady, RO
    Reiser, J
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (11) : 8873 - 8883
  • [43] The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis
    Nascimbeni, M
    Bouyac, M
    Rey, F
    Spire, B
    Clavel, F
    [J]. JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 1945 - 1950
  • [44] CONSERVATION OF AMINO-ACID-SEQUENCE MOTIFS IN LENTIVIRUS VIF PROTEINS
    OBERSTE, MS
    GONDA, MA
    [J]. VIRUS GENES, 1992, 6 (01) : 95 - 102
  • [45] Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non permissive' T lymphoid cells stably infected with selectable HIV-1
    Ochsenbauer, C
    Wilk, T
    Bosch, V
    [J]. JOURNAL OF GENERAL VIROLOGY, 1997, 78 : 627 - 635
  • [46] Role of Vif in stability of the human immunodeficiency virus type 1 core
    Ohagen, Å
    Gabuzda, D
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (23) : 11055 - 11066
  • [47] PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993
  • [48] COMPARATIVE ANALYSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND HIV-2 VIF MUTANTS
    REDDY, TR
    KRAUS, G
    YAMADA, O
    LOONEY, DJ
    SUHASINI, M
    WONGSTAAL, F
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (06) : 3549 - 3553
  • [49] Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography
    Richieri, SP
    Bartholomew, R
    Aloia, RC
    Savary, J
    Gore, R
    Holt, J
    Ferre, F
    Musil, R
    Tian, HR
    Trauger, R
    Lowry, P
    Jensen, F
    Carlo, DJ
    Maigetter, RZ
    Prior, CP
    [J]. VACCINE, 1998, 16 (2-3) : 119 - 129
  • [50] Saib A, 1997, J VIROL, V71, P1155